79 related articles for article (PubMed ID: 2284161)
21. Treatment of Turner's syndrome with estrogen.
Levine LS
Pediatrics; 1978 Dec; 62(6 Pt 2):1178-83. PubMed ID: 724356
[No Abstract] [Full Text] [Related]
22. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
[TBL] [Abstract][Full Text] [Related]
23. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome.
Collett-Solberg PF; Pessoa de Queiroz AN; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM
Growth Horm IGF Res; 2006 Aug; 16(4):240-6. PubMed ID: 16908209
[TBL] [Abstract][Full Text] [Related]
24. Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome.
Ross JL; Roeltgen D; Feuillan P; Kushner H; Cutler GB
J Clin Endocrinol Metab; 1998 Sep; 83(9):3198-204. PubMed ID: 9745426
[TBL] [Abstract][Full Text] [Related]
25. Change in speaking fundamental frequency in hormone-treated patients with Turner's syndrome--a longitudinal study of four cases.
Andersson-Wallgren G; Albertsson-Wikland K
Acta Paediatr; 1994 Apr; 83(4):452-5. PubMed ID: 8025411
[TBL] [Abstract][Full Text] [Related]
26. Turner's syndrome: treatment of 203 patients with recombinant human growth hormone for one year. A multicentre study.
Takano K; Shizume K; Hibi I
Acta Endocrinol (Copenh); 1989 May; 120(5):559-68. PubMed ID: 2658450
[TBL] [Abstract][Full Text] [Related]
27. Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age-matched normal females and effect of chronic estrogen replacement therapy.
Cuttler L; Van Vliet G; Conte FA; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1985 Jun; 60(6):1087-92. PubMed ID: 4039732
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Turner's syndrome.
Conway GS; Davies M; Merry A
Lancet; 1996 Dec; 348(9041):1590-1. PubMed ID: 8950906
[No Abstract] [Full Text] [Related]
29. Growth hormone treatment in Turner's syndrome.
Takano K; Hizuka N; Shizume K
Acta Paediatr Scand Suppl; 1986; 325():58-63. PubMed ID: 3473892
[TBL] [Abstract][Full Text] [Related]
30. Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome.
Ross JL; Long LM; Skerda M; Cassorla F; Kurtz D; Loriaux DL; Cutler GB
J Pediatr; 1986 Dec; 109(6):950-3. PubMed ID: 3537251
[TBL] [Abstract][Full Text] [Related]
31. Serum thymidine activity and somatomedin-C levels in children and adolescents with Turner's syndrome: effect of chronic estrogen and progestogen replacement therapy.
Guidoux S; Bozzola M; Larizza D; Schimpff RM
Horm Res; 1986; 24(4):256-62. PubMed ID: 3781484
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Turner's syndrome--a concern.
Masters KW
Lancet; 1996 Sep; 348(9028):681-2. PubMed ID: 8782767
[No Abstract] [Full Text] [Related]
33. Oestrogen replacement in young women with Turner's syndrome.
Conway GS
Clin Endocrinol (Oxf); 2001 Feb; 54(2):157-8. PubMed ID: 11207628
[No Abstract] [Full Text] [Related]
34. Effects of human growth hormone therapy on melanocytic naevi.
Bourguignon JP; Piérard GE; Ernould C; Heinrichs C; Craen M; Rochiccioli P; Arrese JE; Franchimont C
Lancet; 1993 Jun; 341(8859):1505-6. PubMed ID: 8099381
[TBL] [Abstract][Full Text] [Related]
35. Factors attenuating growth promoting effect of growth hormone therapy for Turner's syndrome.
Sato T; Miyamori C; Kajiwara S; Miyagawa K; Shimizu M
Endocrinol Jpn; 1988 Oct; 35(5):725-31. PubMed ID: 3146501
[TBL] [Abstract][Full Text] [Related]
36. The effect of human growth hormone therapy on L-(methyl-2H3)-leucine turnover and urinary pseudouridine concentration in patients with Ullrich-Turner syndrome.
Böhles H; Brendel L; Förster H; Träger K; Vogt J; Georgieff M
Eur J Pediatr; 1996 Apr; 155(4):275-80. PubMed ID: 8777919
[TBL] [Abstract][Full Text] [Related]
37. Isotopic and nonisotopic assays for measuring somatotropin compared: re-evaluation of cutoff value in provocative tests.
Banfi G; Marinelli M; Casari E; Murone M; Bonini P
Clin Chem; 1991 Feb; 37(2):273-6. PubMed ID: 1993338
[TBL] [Abstract][Full Text] [Related]
38. Liver dysfunction in Turner syndrome and its relationship to exogenous oestrogen.
Lee MC; Conway GS
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1141-5. PubMed ID: 23603786
[TBL] [Abstract][Full Text] [Related]
39. Therapy: Turner syndrome--estrogen therapy in childhood normalizes pubertal onset.
Osório J
Nat Rev Endocrinol; 2014 Jul; 10(7):379. PubMed ID: 24821325
[No Abstract] [Full Text] [Related]
40. Ultra-low-dose estrogen therapy for female hypogonadism.
Hasegawa Y; Itonaga T; Ikegawa K; Nishigaki S; Kawai M; Koga E; Sakakibara H; Ross JL
Clin Pediatr Endocrinol; 2020; 29(2):49-53. PubMed ID: 32313372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
